Atrial Fibrillation
Conditions
Brief summary
The Atrial Fibrillation Ablation Registry (AFib Ablation Registry™) is designed to assess the prevalence, demographics, management, and outcomes of patients undergoing percutaneous catheter ablation procedures to treat atrial fibrillation (AF).
Detailed description
The Atrial Fibrillation Ablation Registry (AFib Ablation Registry™) is designed to assess the prevalence, demographics, management, and outcomes of patients undergoing percutaneous catheter ablation procedures to treat atrial fibrillation (AF). Patient-level data will be submitted by participating hospitals on a quarterly basis to the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR™). The primary aims of the AFib Ablation Registry are to optimize the outcomes and management of patients through the implementation of evidence-based guideline recommendations in clinical practice, facilitate efforts to improve the quality and safety for patients undergoing percutaneous catheter ablation procedures, investigate novel quality improvement methods and provide risk-adjusted assessment of patients for comparison with nationwide NCDR data. The secondary purpose of the AFib Ablation Registry is to serve as a rich source of clinical data to support assessments of short- and long-term safety, comparative and cost effectiveness research, and as a scalable data infrastructure for post market studies.
Interventions
A procedure used to treat an irregular heart rhythm (arrhythmia)
Sponsors
Study design
Eligibility
Inclusion criteria
1. Adult patients 2. 18 years and older 3. Undergoing percutaneous catheter ablation procedures to treat atrial fibrillation
Exclusion criteria
1\. none
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Unsuccessful treatment rate | 1 year | measured by the number of repeated procedure |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Adverse Events | 1 year | Number of participants with adverse events that are related to treatment (i.e. cardiac tamponade, periprocedural stroke, pulmonary vein stenosis, esophageal damage, etc) |
Countries
United States